Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Future Oncology (London, England)
|
March 9, 2013
Antibody-drug conjugates for the treatment of B-cell non-Hodgkin's lymphoma and leukemia
Yu-Waye Chu, Andrew Polson
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 18, 2008
Murine models of chronic graft-versus-host disease: insights and unresolved issues
Yu-Waye Chu, Ronald E Gress
The AAPS Journal
|
February 23, 2017
Assessment of Correlation Between Early and Late Efficacy Endpoints to Identify Potential Surrogacy Relationships in Non-Hodgkin Lymphoma: a Literature-Based Meta-analysis of 108 Phase II and Phase III Studies
Rui Zhu, Dan Lu, Yu-Waye Chu, et al.
NPJ Systems Biology and Applications
|
August 30, 2020
Mitigating the risk of cytokine release syndrome in a Phase I trial of CD20/CD3 bispecific antibody mosunetuzumab in NHL: impact of translational system modeling
Iraj Hosseini, Kapil Gadkar, Eric Stefanich, et al.
Blood
|
July 29, 2008
Exogenous insulin-like growth factor 1 enhances thymopoiesis predominantly through thymic epithelial cell expansion
Yu-Waye Chu, Sabrina Schmitz, Baishakhi Choudhury, et al.
Blood
|
May 8, 2004
Exogenous IL-7 increases recent thymic emigrants in peripheral lymphoid tissue without enhanced thymic function
Yu-Waye Chu, Sarfraz A Memon, Susan O Sharrow, et al.
Blood
|
July 1, 2004
Flt3 ligand enhances thymic-dependent and thymic-independent immune reconstitution
Terry J Fry, Manoj Sinha, Matthew Milliron, et al.
Blood
|
August 13, 2008
CCL25 increases thymopoiesis after androgen withdrawal
Kirsten M Williams, Philip J Lucas, Catherine V Bare, et al.
Blood
|
June 22, 2006
Dysregulation of IL-15-mediated T-cell homeostasis in TGF-beta dominant-negative receptor transgenic mice
Philip J Lucas, Seong-Jin Kim, Crystal L Mackall, et al.
Cancer Chemotherapy and Pharmacology
|
August 14, 2012
A population pharmacokinetic/pharmacodynamic model of thrombocytopenia characterizing the effect of trastuzumab emtansine (T-DM1) on platelet counts in patients with HER2-positive metastatic breast cancer
Brendan C Bender, Franziska Schaedeli-Stark, Reinhold Koch, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Future Oncology (London, England)
|
March 9, 2013
Antibody-drug conjugates for the treatment of B-cell non-Hodgkin's lymphoma and leukemia
Yu-Waye Chu, Andrew Polson
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 18, 2008
Murine models of chronic graft-versus-host disease: insights and unresolved issues
Yu-Waye Chu, Ronald E Gress
The AAPS Journal
|
February 23, 2017
Assessment of Correlation Between Early and Late Efficacy Endpoints to Identify Potential Surrogacy Relationships in Non-Hodgkin Lymphoma: a Literature-Based Meta-analysis of 108 Phase II and Phase III Studies
Rui Zhu, Dan Lu, Yu-Waye Chu, et al.
NPJ Systems Biology and Applications
|
August 30, 2020
Mitigating the risk of cytokine release syndrome in a Phase I trial of CD20/CD3 bispecific antibody mosunetuzumab in NHL: impact of translational system modeling
Iraj Hosseini, Kapil Gadkar, Eric Stefanich, et al.
Blood
|
July 29, 2008
Exogenous insulin-like growth factor 1 enhances thymopoiesis predominantly through thymic epithelial cell expansion
Yu-Waye Chu, Sabrina Schmitz, Baishakhi Choudhury, et al.
Blood
|
May 8, 2004
Exogenous IL-7 increases recent thymic emigrants in peripheral lymphoid tissue without enhanced thymic function
Yu-Waye Chu, Sarfraz A Memon, Susan O Sharrow, et al.
Blood
|
July 1, 2004
Flt3 ligand enhances thymic-dependent and thymic-independent immune reconstitution
Terry J Fry, Manoj Sinha, Matthew Milliron, et al.
Blood
|
August 13, 2008
CCL25 increases thymopoiesis after androgen withdrawal
Kirsten M Williams, Philip J Lucas, Catherine V Bare, et al.
Blood
|
June 22, 2006
Dysregulation of IL-15-mediated T-cell homeostasis in TGF-beta dominant-negative receptor transgenic mice
Philip J Lucas, Seong-Jin Kim, Crystal L Mackall, et al.
Cancer Chemotherapy and Pharmacology
|
August 14, 2012
A population pharmacokinetic/pharmacodynamic model of thrombocytopenia characterizing the effect of trastuzumab emtansine (T-DM1) on platelet counts in patients with HER2-positive metastatic breast cancer
Brendan C Bender, Franziska Schaedeli-Stark, Reinhold Koch, et al.
Page
of 3